Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lichuan Liu

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Biomedical Chromatography : BMC|February 8, 2012
Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0834 and its metabolite in human plasma using semi-automated 96-well protein precipitationYoung G Shin, Steve A Jones, Stan C Murakami, et al.
Journal of Clinical Pharmacology|May 23, 2018
Effect of OATP1B1/1B3 Inhibitor GDC-0810 on the Pharmacokinetics of Pravastatin and Coproporphyrin I/III in Healthy Female SubjectsLichuan Liu, Sravanthi Cheeti, Kenta Yoshida, et al.
Journal of Clinical Pharmacology|June 6, 2015
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studiesLichuan Liu, Akintunde Bello, Mark J Dresser, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 31, 2024
Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysisKun Wang, Yusong Zhu, Fengyan Xu, et al.
NPJ Systems Biology and Applications|September 8, 2017
Erratum: Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Pharmaceutical Research|October 28, 2018
Correction to: Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy SubjectsSravanthi Cheeti, Hao Helen Hou, Eric Nelson, et al.
Pharmaceutical Research|October 17, 2018
Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy SubjectsSravanthi Cheeti, Hao Helen Hou, Eric Nelson, et al.
NPJ Systems Biology and Applications|June 27, 2017
Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the ratYiqun Ling, Junlan Zhang, Bao Luo, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 18, 2018
Practical strategies when using a stable isotope labeled microtracer for absolute bioavailability assessment: A case study of a high oral dose clinical candidate GDC-0810Buyun Chen, Pingping Lu, Dugan Freeman, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Biomedical Chromatography : BMC|February 8, 2012
Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0834 and its metabolite in human plasma using semi-automated 96-well protein precipitationYoung G Shin, Steve A Jones, Stan C Murakami, et al.
Journal of Clinical Pharmacology|May 23, 2018
Effect of OATP1B1/1B3 Inhibitor GDC-0810 on the Pharmacokinetics of Pravastatin and Coproporphyrin I/III in Healthy Female SubjectsLichuan Liu, Sravanthi Cheeti, Kenta Yoshida, et al.
Journal of Clinical Pharmacology|June 6, 2015
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studiesLichuan Liu, Akintunde Bello, Mark J Dresser, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 31, 2024
Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysisKun Wang, Yusong Zhu, Fengyan Xu, et al.
NPJ Systems Biology and Applications|September 8, 2017
Erratum: Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Pharmaceutical Research|October 28, 2018
Correction to: Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy SubjectsSravanthi Cheeti, Hao Helen Hou, Eric Nelson, et al.
Pharmaceutical Research|October 17, 2018
Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy SubjectsSravanthi Cheeti, Hao Helen Hou, Eric Nelson, et al.
NPJ Systems Biology and Applications|June 27, 2017
Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Hepatology (Baltimore, Md.)|June 9, 2004
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the ratYiqun Ling, Junlan Zhang, Bao Luo, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 18, 2018
Practical strategies when using a stable isotope labeled microtracer for absolute bioavailability assessment: A case study of a high oral dose clinical candidate GDC-0810Buyun Chen, Pingping Lu, Dugan Freeman, et al.
Pageof 6